content

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in...

Canadian companies complete handover of drugs rights

Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. With the deal, announced...

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as...

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as...

LANXESS completes sale of ARLANXEO to Saudi Aramco

Specialty chemicals company LANXESS , December 31, 2018, completed the sale of its remaining 50 percent interest in the rubber company ARLANXEO to Saudi...

North Estonia Medical Centre expands Clinerionโ€™s Patient Network Explorer hospital network in Estonia

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia,...

A special event organized by Turkish Cargo for IATA CEIV Pharma Workshop

Turkish Cargo organized a Special event titled 'Turkish Cargo & IATA CEIV Pharma Workshopโ€™ for the leading pharmaceutical companies, officials from IATA, agents and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read